Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 77

1.

Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three years.

Wabe N, Sorich MJ, Wechalekar MD, Cleland LG, McWilliams L, Lee A, Spargo L, Metcalf RG, Hall C, Proudman SM, Wiese MD.

Arthritis Res Ther. 2015 Mar 8;17(1):48. doi: 10.1186/s13075-015-0562-0.

2.

Synovial fluid and plasma n3 long chain polyunsaturated fatty acids in patients with inflammatory arthritis.

Moghaddami M, James M, Proudman S, Cleland LG.

Prostaglandins Leukot Essent Fatty Acids. 2015 Mar 16. pii: S0952-3278(15)00061-7. doi: 10.1016/j.plefa.2015.02.005. [Epub ahead of print]

PMID:
25817850
3.

Is there a link between carbamylation and citrullination in periodontal disease and rheumatoid arthritis?

Bright R, Proudman SM, Rosenstein ED, Bartold PM.

Med Hypotheses. 2015 Mar 6. pii: S0306-9877(15)00111-5. doi: 10.1016/j.mehy.2015.03.006. [Epub ahead of print]

PMID:
25801344
4.

Prospects for improving outcomes in systemic sclerosis-related pulmonary hypertension.

Thakkar V, Nikpour M, Stevens WM, Proudman SM.

Intern Med J. 2015 Mar;45(3):248-54. doi: 10.1111/imj.12691.

PMID:
25735576
5.

Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) - Report from OMERACT CTD-ILD Working Group.

Khanna D, Mittoo S, Aggarwal R, Proudman SM, Dalbeth N, Matteson EL, Brown K, Flaherty K, Wells AU, Seibold JR, Strand V.

J Rheumatol. 2015 Mar 1. pii: jrheum.141182. [Epub ahead of print]

PMID:
25729034
6.

The role and utility of measuring red blood cell methotrexate polyglutamate concentrations in inflammatory arthropathies-a systematic review.

Mohamed HJ, Sorich MJ, Kowalski SM, McKinnon R, Proudman SM, Cleland L, Wiese MD.

Eur J Clin Pharmacol. 2015 Apr;71(4):411-23. doi: 10.1007/s00228-015-1819-x. Epub 2015 Feb 18.

PMID:
25687918
7.

A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis.

Hao Y, Thakkar V, Stevens W, Morrisroe K, Prior D, Rabusa C, Youssef P, Gabbay E, Roddy J, Walker J, Zochling J, Sahhar J, Nash P, Lester S, Rischmueller M, Proudman SM, Nikpour M.

Arthritis Res Ther. 2015 Jan 18;17(1):7. doi: 10.1186/s13075-015-0517-5.

8.

Potential role of the lectin pathway of complement in the pathogenesis and disease manifestations of systemic sclerosis: a case-control and cohort study.

Osthoff M, Ngian GS, Dean MM, Nikpour M, Stevens W, Proudman S, Eisen DP, Sahhar J.

Arthritis Res Ther. 2014 Nov 18;16(6):480. doi: 10.1186/s13075-014-0480-6.

9.

A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquine.

Wojciechowski J, Wiese MD, Proudman SM, Foster DJ, Upton RN.

Br J Clin Pharmacol. 2015 May;79(5):777-88. doi: 10.1111/bcp.12553.

PMID:
25394211
10.

An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3.

Zochling J, Newell F, Charlesworth JC, Leo P, Stankovich J, Cortes A, Zhou Y, Stevens W, Sahhar J, Roddy J, Nash P, Tymms K, Rischmueller M, Lester S, Proudman S, Brown MA.

Arthritis Res Ther. 2014 Oct 21;16(5):438. doi: 10.1186/s13075-014-0438-8.

11.

The rheumatoid arthritis susceptibility polymorphism PTPN22 C1858T is not associated with leflunomide response or toxicity.

Hopkins AM, O'Doherty CE, Foster DJ, Suppiah V, Upton RN, Spargo LD, Cleland LG, Proudman SM, Wiese MD.

J Clin Pharm Ther. 2014 Oct;39(5):555-60. doi: 10.1111/jcpt.12189. Epub 2014 Jul 8.

PMID:
25040563
12.

Does periodontal treatment influence clinical and biochemical measures for rheumatoid arthritis? A systematic review and meta-analysis.

Kaur S, Bright R, Proudman SM, Bartold PM.

Semin Arthritis Rheum. 2014 Oct;44(2):113-22. doi: 10.1016/j.semarthrit.2014.04.009. Epub 2014 Apr 28.

PMID:
24880982
13.

RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.

Cleland LG, Proudman SM, James MJ.

J Natl Cancer Inst. 2014 Apr;106(4):dju022. doi: 10.1093/jnci/dju022. Epub 2014 Mar 31. No abstract available.

14.

Rheumatoid arthritis and lung disease: from mechanisms to a practical approach.

Lake F, Proudman S.

Semin Respir Crit Care Med. 2014 Apr;35(2):222-38. doi: 10.1055/s-0034-1371542. Epub 2014 Mar 25. Review.

PMID:
24668537
15.

Changes in peripheral blood B cell subsets at diagnosis and after treatment with disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: correlation with clinical and laboratory parameters.

McComish J, Mundy J, Sullivan T, Proudman SM, Hissaria P.

Int J Rheum Dis. 2014 Mar 2. doi: 10.1111/1756-185X.12325. [Epub ahead of print]

PMID:
24589014
16.

The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosis.

Morrisroe KB, Stevens W, Nandurkar H, Prior D, Thakkar V, Roddy J, Zochling J, Sahhar J, Tymms K, Sturgess A, Major G, Kermeen F, Hill C, Walker J, Nash P, Gabbay E, Youssef P, Proudman SM, Nikpour M.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-133-7. Epub 2014 Feb 24.

PMID:
24564981
17.

Pharmacogenomics of NAT2 and ABCG2 influence the toxicity and efficacy of sulphasalazine containing DMARD regimens in early rheumatoid arthritis.

Wiese MD, Alotaibi N, O'Doherty C, Sorich MJ, Suppiah V, Cleland LG, Proudman SM.

Pharmacogenomics J. 2014 Aug;14(4):350-5. doi: 10.1038/tpj.2013.45. Epub 2014 Jan 7.

PMID:
24394199
18.

Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials.

Saketkoo LA, Mittoo S, Huscher D, Khanna D, Dellaripa PF, Distler O, Flaherty KR, Frankel S, Oddis CV, Denton CP, Fischer A, Kowal-Bielecka OM, LeSage D, Merkel PA, Phillips K, Pittrow D, Swigris J, Antoniou K, Baughman RP, Castelino FV, Christmann RB, Christopher-Stine L, Collard HR, Cottin V, Danoff S, Highland KB, Hummers L, Shah AA, Kim DS, Lynch DA, Miller FW, Proudman SM, Richeldi L, Ryu JH, Sandorfi N, Sarver C, Wells AU, Strand V, Matteson EL, Brown KK, Seibold JR; CTD-ILD Special Interest Group.

Thorax. 2014 May;69(5):428-36. doi: 10.1136/thoraxjnl-2013-204202. Epub 2013 Dec 24. Erratum in: Thorax. 2014 Sep;69(9):834. CTD-ILD Special Interest Group [added]; multiple investigator names added.

19.

The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study.

Thakkar V, Stevens W, Prior D, Youssef P, Liew D, Gabbay E, Roddy J, Walker JG, Zochling J, Sahhar J, Nash P, Lester S, Rischmueller M, Proudman SM, Nikpour M.

Arthritis Res Ther. 2013;15(6):R193.

20.

Cardiac arrhythmias and conduction defects in systemic sclerosis.

Vacca A, Meune C, Gordon J, Chung L, Proudman S, Assassi S, Nikpour M, Rodriguez-Reyna TS, Khanna D, Lafyatis R, Matucci-Cerinic M, Distler O, Allanore Y; Scleroderma Clinical Trial Consortium Cardiac Subcommittee.

Rheumatology (Oxford). 2014 Jul;53(7):1172-7. doi: 10.1093/rheumatology/ket377. Epub 2013 Nov 15. Review.

PMID:
24241036
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk